Showing results (11-20 of 99) with videos related to
Sort By:
Pageof 10
Current Pharmaceutical Design|December 17, 2008
Nocturnal urinary cortisol excretion over a randomized controlled trial with paroxetine vs. placebo combined with relaxation training or aerobic exercise in panic disorderD Wedekind, A Sprute, A Broocks, et al.Pharmacopsychiatry|July 1, 1997
Urinary excretion of cortisol, norepinephrine, testosterone, and melatonin in panic disorderB Bandelow, G Sengos, D Wedekind, et al.Psychiatry Research|September 7, 2000
Diurnal variation of cortisol in panic disorderB Bandelow, D Wedekind, V Sandvoss, et al.European Archives of Psychiatry and Clinical Neuroscience|November 21, 2015
Functional MRI activation in response to panic-specific, non-panic aversive, and neutral pictures in patients with panic disorder and healthy controlsK R Engel, K Obst, B Bandelow, et al.International Clinical Psychopharmacology|June 1, 1995
Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia ScaleB BandelowMMW Fortschritte Der Medizin|June 20, 2002
[Behavior therapy and antidepressive drugs. What helps with anxiety?]B BandelowEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 6, 2003
5-HT1A responsivity in patients with panic disorder before and after treatment with aerobic exercise, clomipramine or placeboAndreas Broocks, T Meyer, M Opitz, et al.International Clinical Psychopharmacology|September 4, 1998
Safety and tolerance of zolpidem in the treatment of disturbed sleep: a post-marketing surveillance of 16944 casesG Hajak, B BandelowFortschritte Der Neurologie-Psychiatrie|October 1, 1994
[Recommendations for the use of measuring instruments in clinical anxiety research]B Bandelow, J MargrafPageof 10